Light-activated pathogen-killing molecules and uses thereof
AssigneeEpic Ventures Inc.
InventorsHeather BUCKLEY, Jeremy WULFF, Peter BERRANG, Mathieu LEPAGE, Stefania MUSOLINO
Life of this patent
Estimating the term…
Loading patent…
AssigneeEpic Ventures Inc.
InventorsHeather BUCKLEY, Jeremy WULFF, Peter BERRANG, Mathieu LEPAGE, Stefania MUSOLINO
Estimating the term…
A series of novel molecular conjugates is disclosed herein, consisting of a photosensitizer moiety chemically bonded to at least one diazirine moiety. Such conjugates react in air and/or water with non-coherent visible light to form singlet oxygen, an energetic species known to be highly toxic to abroad range of pathogens, including bacteria, fungi, microbial biofilms and viruses. Such non-specific cellular damage limits the pathogen's ability to evolve into a resistant form. The diazirine moiety of the conjugate enables the reagent to be adhesively bonded to a plethora of substrates, such as, for example, polymers, non-woven fabrics, surgical masks and gloves, hospital gowns, hospital surfaces (such as counters, mattresses, curtains) medical implants, bandages, wound dressings, or air-filters. The resulting treated substrates act as an effective pathogen-killing barrier, providing protection against the spread of such pathogens to non-infected persons.
A molecular conjugate comprising a photosensitizer moiety chemically bonded to at least one diazirine moiety.
The conjugate zinc 5,10,15,20-tetra(4-pyridyl)-21H,23H-porphine tetrakis(4-[3-(trifluoromethyl)-3H-diazirin-3-yl]benzobromide).
Dependencies are inferred from the claim text.